Clinical evaluation of a method for detecting superficial transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following topical application of 5-aminolevulinic acid: Preliminary results

BACKGROUND AND OBJECTIVE: In bladder cancer, conventional white light endoscopic examination of the bladder does not provide adequate information about the presence of "flat" urothelial lesions such as carcinoma in situ. In the present investigation, we examine a new technique for the photodetection of such lesions by the imaging of protoporphyrin IX (PpIX) fluorescence following topical application of 5-aminolevulinic acid (ALA). STUDY DESIGN/MATERIALS AND METHODS: Several hours after bladder instillation of an aqueous solution of ALA in 34 patients, a Krypton ion laser or a filtered Xenon arc-lamp was used to excite PpIX fluorescence. Tissue samples for histological analysis were taken while observing the bladder wall either by means of a video camera, or by direct endoscopic observation. RESULTS: A good correlation was found between the PpIX fluorescence and the histopathological diagnosis. On a total of 215 biopsies, 143 in fluorescent and 72 in nonfluorescent areas, all visible tumors on white light cytoscopy appeared in a bright red fluorescence with the photodetection technique. In addition, this method permitted to discover 47 unsuspected carcinomatous lesions on white light observation, among which 40% were carcinoma in situ. CONCLUSION: PpIX fluorescence induced by instillation into the bladder of 5-ALA is an efficient method of mapping the mucosa in bladder carcinoma.

Published in:
Lasers in Surgery and Medicine, 20, 4, 402-408
Copyright 2003 U.S. National Library of Medicine
Department of Urology, CHUV Hospital, Lausanne, Switzerland
Journal; Article; (JOURNAL ARTICLE)
Female; Human; Male; Support, Non-U.S. Gov't
Administration, Cutaneous; Administration, Intravesical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid: AD, administration & dosage; *Aminolevulinic Acid: DU, diagnostic use; *Bladder Neoplasms: DI, diagnosis; *Carcinoma, Transitional Cell: DI, diagnosis; Evaluation Studies; Fluorescence; Middle Age; Photofluorography; *Photosensitizing Agents: DU, diagnostic use; *Protoporphyrins: DU, diagnostic use
0 (Photosensitizing Agents); 0 (Protoporphyrins)

 Record created 2007-07-20, last modified 2018-12-03

Rate this document:

Rate this document:
(Not yet reviewed)